Bifogade filer
Kurs
+0,45%
Prenumeration
Kalender
Est. tid* | ||
2025-05-09 | N/A | X-dag ordinarie utdelning ORTI B 0.00 SEK |
2025-05-09 | N/A | X-dag ordinarie utdelning ORTI A 0.00 SEK |
2025-05-08 | N/A | Årsstämma |
2025-05-08 | 08:30 | Kvartalsrapport 2025-Q1 |
2025-02-14 | - | Bokslutskommuniké 2024 |
2024-11-08 | - | Kvartalsrapport 2024-Q3 |
2024-08-23 | - | Kvartalsrapport 2024-Q2 |
2024-05-10 | - | X-dag ordinarie utdelning ORTI B 0.00 SEK |
2024-05-10 | - | X-dag ordinarie utdelning ORTI A 0.00 SEK |
2024-05-08 | - | Årsstämma |
2024-05-08 | - | Kvartalsrapport 2024-Q1 |
2024-02-16 | - | Bokslutskommuniké 2023 |
2023-11-10 | - | Kvartalsrapport 2023-Q3 |
2023-08-25 | - | Kvartalsrapport 2023-Q2 |
2023-05-05 | - | X-dag ordinarie utdelning ORTI B 0.00 SEK |
2023-05-05 | - | X-dag ordinarie utdelning ORTI A 0.00 SEK |
2023-05-04 | - | Årsstämma |
2023-05-04 | - | Kvartalsrapport 2023-Q1 |
2023-02-17 | - | Bokslutskommuniké 2022 |
2022-11-11 | - | Kvartalsrapport 2022-Q3 |
2022-08-25 | - | Kvartalsrapport 2022-Q2 |
2022-05-06 | - | X-dag ordinarie utdelning ORTI A 0.00 SEK |
2022-05-06 | - | X-dag ordinarie utdelning ORTI B 0.00 SEK |
2022-05-05 | - | Årsstämma |
2022-04-27 | - | Kvartalsrapport 2022-Q1 |
2022-02-16 | - | Bokslutskommuniké 2021 |
2021-11-12 | - | Kvartalsrapport 2021-Q3 |
2021-08-20 | - | Kvartalsrapport 2021-Q2 |
2021-05-06 | - | X-dag ordinarie utdelning ORTI B 0.00 SEK |
2021-05-06 | - | X-dag ordinarie utdelning ORTI A 0.00 SEK |
2021-05-05 | - | Årsstämma |
2021-04-27 | - | Kvartalsrapport 2021-Q1 |
2021-02-16 | - | Bokslutskommuniké 2020 |
2020-11-10 | - | Kvartalsrapport 2020-Q3 |
2020-08-21 | - | Kvartalsrapport 2020-Q2 |
2020-05-13 | - | X-dag ordinarie utdelning ORTI B 0.00 SEK |
2020-05-13 | - | X-dag ordinarie utdelning ORTI A 0.00 SEK |
2020-05-04 | - | Årsstämma |
2020-04-23 | - | Kvartalsrapport 2020-Q1 |
2020-02-18 | - | Årsstämma |
2020-02-13 | - | Årsstämma |
2020-02-13 | - | Bokslutskommuniké 2019 |
2019-10-25 | - | Årsstämma |
2019-08-22 | - | Kvartalsrapport 2019-Q2 |
2019-05-07 | - | X-dag ordinarie utdelning ORTI A 0.00 SEK |
2019-05-07 | - | X-dag ordinarie utdelning ORTI B 0.00 SEK |
2019-05-06 | - | Årsstämma |
2019-05-03 | - | Kvartalsrapport 2019-Q1 |
2019-02-18 | - | Extra Bolagsstämma 2019 |
2019-02-13 | - | Bokslutskommuniké 2018 |
2018-11-20 | - | Kvartalsrapport 2018-Q3 |
2018-08-24 | - | Kvartalsrapport 2018-Q2 |
2018-05-04 | - | X-dag ordinarie utdelning ORTI B 0.00 SEK |
2018-05-04 | - | X-dag ordinarie utdelning ORTI A 0.00 SEK |
2018-05-03 | - | Årsstämma |
2018-04-30 | - | Kvartalsrapport 2018-Q1 |
2018-02-08 | - | Bokslutskommuniké 2017 |
2017-11-21 | - | Kvartalsrapport 2017-Q3 |
2017-08-22 | - | Kvartalsrapport 2017-Q2 |
2017-05-12 | - | Extra Bolagsstämma 2017 |
2017-05-02 | - | X-dag ordinarie utdelning ORTI B 0.00 SEK |
2017-05-02 | - | X-dag ordinarie utdelning ORTI A 0.00 SEK |
2017-05-02 | - | Kvartalsrapport 2017-Q1 |
2017-04-28 | - | Årsstämma |
2017-02-10 | - | Bokslutskommuniké 2016 |
2016-10-24 | - | Kvartalsrapport 2016-Q3 |
2016-07-13 | - | Kvartalsrapport 2016-Q2 |
2016-05-09 | - | Årsstämma |
2016-05-02 | - | Kvartalsrapport 2016-Q1 |
2016-04-30 | - | X-dag ordinarie utdelning ORTI A 0.00 SEK |
2016-04-30 | - | X-dag ordinarie utdelning ORTI B 0.00 SEK |
2016-02-10 | - | Bokslutskommuniké 2015 |
2015-10-20 | - | Kvartalsrapport 2015-Q3 |
2015-07-13 | - | Kvartalsrapport 2015-Q2 |
2015-04-30 | - | X-dag ordinarie utdelning ORTI B 0.00 SEK |
2015-04-30 | - | X-dag ordinarie utdelning ORTI A 0.00 SEK |
2015-04-29 | - | Årsstämma |
2015-04-29 | - | Kvartalsrapport 2015-Q1 |
2015-02-17 | - | Bokslutskommuniké 2014 |
2014-10-27 | - | Kvartalsrapport 2014-Q3 |
2014-07-11 | - | Kvartalsrapport 2014-Q2 |
2014-04-30 | - | X-dag ordinarie utdelning ORTI B 0.00 SEK |
2014-04-30 | - | X-dag ordinarie utdelning ORTI A 0.00 SEK |
2014-04-29 | - | Årsstämma |
2014-04-29 | - | Kvartalsrapport 2014-Q1 |
2014-02-07 | - | Bokslutskommuniké 2013 |
2013-10-18 | - | Kvartalsrapport 2013-Q3 |
2013-07-12 | - | Kvartalsrapport 2013-Q2 |
2013-04-30 | - | Kvartalsrapport 2013-Q1 |
2013-04-22 | - | X-dag ordinarie utdelning ORTI B 0.00 SEK |
2013-04-22 | - | X-dag ordinarie utdelning ORTI A 0.00 SEK |
2013-04-19 | - | Årsstämma |
2013-02-08 | - | Bokslutskommuniké 2012 |
2012-10-18 | - | Kvartalsrapport 2012-Q3 |
2012-07-12 | - | Kvartalsrapport 2012-Q2 |
2012-05-04 | - | X-dag ordinarie utdelning ORTI B 0.00 SEK |
2012-05-04 | - | X-dag ordinarie utdelning ORTI A 0.00 SEK |
2012-05-03 | - | Årsstämma |
2012-04-20 | - | Kvartalsrapport 2012-Q1 |
2012-02-22 | - | Bokslutskommuniké 2011 |
2011-10-14 | - | Kvartalsrapport 2011-Q3 |
2011-08-12 | - | Kvartalsrapport 2011-Q2 |
2011-05-31 | - | Extra Bolagsstämma 2010 |
2011-05-05 | - | X-dag ordinarie utdelning ORTI B 0.00 SEK |
2011-05-05 | - | X-dag ordinarie utdelning ORTI A 0.00 SEK |
2011-05-04 | - | Årsstämma |
2011-04-15 | - | Kvartalsrapport 2011-Q1 |
2011-02-18 | - | Bokslutskommuniké 2010 |
2010-10-14 | - | Kvartalsrapport 2010-Q3 |
2010-08-12 | - | Kvartalsrapport 2010-Q2 |
2010-05-04 | - | X-dag ordinarie utdelning ORTI B 0.00 SEK |
2010-05-04 | - | X-dag ordinarie utdelning ORTI A 0.00 SEK |
2010-05-03 | - | Årsstämma |
2010-04-22 | - | Kvartalsrapport 2010-Q1 |
2010-02-19 | - | Bokslutskommuniké 2009 |
2009-11-12 | - | Kvartalsrapport 2009-Q3 |
2009-08-14 | - | Kvartalsrapport 2009-Q2 |
2009-05-07 | - | X-dag ordinarie utdelning ORTI B 0.00 SEK |
2009-05-07 | - | X-dag ordinarie utdelning ORTI A 0.00 SEK |
2009-05-06 | - | Årsstämma |
2009-05-06 | - | Kvartalsrapport 2009-Q1 |
1998-04-23 | - | Split ORTI A 1:2 |
Beskrivning
Land | Sverige |
---|---|
Lista | Small Cap Stockholm |
Sektor | Hälsovård |
Industri | Medicinteknik |
A challenging quarter concludes on a positive note with restored delivery pace and several new contracts signed
Significant events for the period July - September 2023
- Ortivus is awarded a contract for the delivery of equipment to Region Sörmland’s ambulance services. The contract pertains to the delivery of Ortivus solutions, MobiMed Monitor for patient monitoring, and MobiMed Life, external defibrillators, to all of the region’s ambulance vehicles. The estimated order value is 10.0 MSEK.
- Ortivus signs a contract for the delivery of MobiMed enRoute to Region Jämtland Härjedalen. The estimated order value is 2.5 MSEK, and the contract duration is 8 years.
- Ortivus signs a contract for the delivery of MobiMed Life to Region Kronoberg. The estimated order value is 4.9 MSEK for the first two years.
- On November 28, 2022, Ortivus was awarded a contract for the delivery of MobiMed ePR and MobiMed enRoute to the ambulance services of Region Jönköpings län. The contract has now been signed by both parties. The contract duration is 5 years with a possible extension of an additional 5 years. The order value is 4.2 MSEK for the initial contract period and an additional 4.2 MSEK upon contract extension.
- Ortivus’ subcontractor, responsible for managing the server system connected to MobiMed ePR, the company’s electronic record system, is subjected to a cyber-attack. This results in the service becoming unavailable for a period of time for some of the company’s British customers.
- Ortivus enters into an agreement for a credit line of 8.0 MSEK with the company’s main shareholder, Ponderus Invest, in order to strengthen the company’s liquidity position.
Significant events after end of the period
- Ortivus’ President and CEO, Reidar Gårdebäck has decided to leave the company after nearly 5 years of service. The recruitment process has been initiated, and Gårdebäck will remain with the company until a replacement has been recruited, which is expected to occur in the spring of 2024.
- The Northern Ireland Ambulance Service chooses to upgrade its MobiMed system with new hardware. The order value is estimated to be 3.1 MSEK.
- Ortivus initiates a process for cost reimbursements regarding the cyber-attack.
- To strengthen the company’s liquidity position after the previous cyber-attack, Ortivus has entered into an agreement with Ponderus Invest regarding a bridge loan of 4.0 MSEK.
- MobiMed ePR, the company’s electronic patient records system, has been restored for all British customers after the previous cyber-attack on a subcontractor’s data center.
July - September 2023
- Net sales amounted to 16.6 (20.2) MSEK.
- The gross margin amounted to 29% (44%).
- EBITDA amounted to -10.9 (0.2) MSEK.
- Earnings after tax per share before and after dilution amounted to -0.25 (0.01) SEK.
- Operating cash flow before changes in working capital amounted to -9.2 (0.8) MSEK.
January - September 2023
- Net sales amounted to 65.3 (71.2) MSEK.
- The gross margin amounted to 40% (50%).
- EBITDA amounted to -15.5 (5.7) MSEK.
- Earnings after tax per share before and after dilution amounted to -0.35 (0.13) SEK.
- Operating cash flow before changes in working capital amounted to -12.0 (5.9) MSEK.
Jul-Sep 2023 | Jul-Sep 2022 | Jan-Sep 2023 | Jan-Sep 2022 | Jan-Dec 2022 | |
Net sales (MSEK) | 16.6 | 20.2 | 65.3 | 71.2 | 104.5 |
Gross margin (%) | 29% | 44% | 40% | 50% | 47% |
Operating profit (MSEK) | -11.0 | 0.0 | -15.2 | 5.5 | 5.8 |
Operating margin (%) | -67% | 0% | -23% | 8% | 6% |
EBITDA (MSEK) | -8.6 | 2.1 | -10.7 | 9.1 | 10.2 |
Adjusted EBITDA, (MSEK) | -2.1 | 2.1 | -4.1 | 9.1 | 10.2 |
Contacts
For further information, please contact
Reidar Gårdebäck, CEO
Telefon +46 8 446 45 00
About Ortivus
Ortivus develops and commercialises MobiMed, e-health and medical technology solutions for a safer and more efficient healthcare. The company was founded in 1985 and is today a leading provider of mobile digital solutions for prehospital care, worldwide. Ortivus' innovations are based on in-depth expertise in cardiology as well as decades of development together with users and customers. The company's headquarters are located in Danderyd, Stockholm. The company has, since 1998, a wholly owned subsidiary based in the United Kingdom and since 2022, a wholly owned subsidiary based in Denmark.
MobiMed is a modular platform that connects and enable real-time information sharing throughout the prehospital care chain. It is currently used by over 12,000 paramedics in over 2,700 emergency vehicles. The platform, MobiMed, consists of several product modules that are completely integrated but can also be used stand-alone. MobiMed comprises four main solutions: MobiMed Monitor, that measures, monitors and shares patients' vital parameters and ECG in real-time, MobiMed ePR, - an electronic patient record for decision support, collection of patient data and clinical documentation, MobiMed enRoute, - a tool for navigation and case management, and MobiMed Life - a range of stand-alone defibrillators.
MobiMed saves vital seconds and enable healthcare professionals make the right decisions in critical situations. MobiMed also contributes to improved quality of care and saved resources.
Ortivus Class A and Class B shares are listed on the NASDAQ Stockholm Small Cap list.
Read more about Ortivus at www.ortivus.com
This information is information that Ortivus is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 2023-11-10 08:30 CET.